8-K·October 15, 2026 at 7:30 AM EDT·3 sources
Opko Health, Inc.: Material agreement
LH -0.3%OPKLAZ
LH · last 30 trading days+3.7% since the news
News
acquisition, log scale$872M
$100M$1B$10B$100B
What happened
- Labcorp agreed to acquire select BioReference Health assets from OPKO Health for $722 million in cash at closing, plus up to $150 million tied to 4Kscore Test revenue.
- The assets include clinical and women’s health testing, urology, corrections testing, more than 80 patient service centers and the 4Kscore Test.
- The transaction requires regulatory approvals and customary closing conditions; the companies will operate independently until closing.
Cash at closing
$722 million
Maximum earnout
$150 million
Maximum transaction value
$872 million
Expected first-year business revenue
approximately $250 million
Why it matters
The transaction expands Labcorp’s specialty diagnostics platform and patient-service-center network while supporting OPKO’s focus on its biopharmaceutical business. Advisors and regulatory conditions are relevant to healthcare M&A execution and valuation.
What to watch. Regulatory approvals, customary closing conditions and any purchase-price adjustment based on closing business revenues.
Deal terms
acquisition
Labcorp → Select assets of BioReference Health
Value
$872M
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- First reported by PR NewswireOct 15Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
- MedTech Dive reportsOct 15Labcorp to buy BioReference assets for up to $872M
- 8-K current reportOct 15Opko Health, Inc.: Material agreement
Who is involved
acquiringOpko Health, Inc.: Material agreementSelect assets of BioReference HealthtargetLabcorpLH · buyerLazardLAZHogan Lovells Cadwalader US LLPParker PoePiper Sandler & Co.Greenberg Traurig P.A.OPKO HealthOPK
CompanyAdvisorThe deal
Sources (3)
- PR NewswireOct 15Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
- MedTech DiveOct 15Labcorp to buy BioReference assets for up to $872M
- SEC EDGAROct 15Opko Health, Inc.: Material agreement
Related
- Oct 23 · Oura sues rival Ultrahuman again, threatening its U.S. smart ring comeback
- Oct 21 · Labcorp Declares Quarterly Dividend
- Oct 22 · Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential
- Oct 22 · Labcorp to buy Myriad’s prenatal health testing unit for $210M
- Oct 22 · Lazard, Inc.: Results of operations
- Oct 21 · Lazard Declares Quarterly Dividend of $0.50 per Share
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.